← 홈

HER2+ 유방암 · HER2

245개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 245개
ADCBiologicstaleShengjing HospitalPhase 2

Next-generation Site-specific human epidermal growth factor receptor 2 (HER2, Next-generation Site-specific human epidermal growth factor receptor 2, Next-generation Site-specific human epidermal growth factor receptor 2 (HER2)-targeting Antibody-drug Conjugate (ARX788))

Breast Neoplasms · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleGilead SciencesPreclinical

ADC (Non-Investigational Antibody-Drug Conjugates, Non-Investigational Antibody-Drug Conjugates (ADC))

HER2-negative Breast Cancer; HER2 Negative Breast Carcinoma · HER2

#HER2#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleOrum Therapeutics USA, Inc.Phase 1

ORM-5029 (ORM-5029)

HER2-positive Breast Cancer; HER-2 Protein Overexpression · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 1

durvalumab (Imfinzi, Obinutuzumab, naptumomab estafenatox and durvalumab)

ER+ Breast Cancer; Ovarian Cancer · HER2

#HER2#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleBiocon Biologics UK LtdPhase 3

trastuzumab (Herceptin, PERT-IJS plus trastuzumab, carboplatin and docetaxel)

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleNorthwestern UniversityPhase 1

PI3K inhibitor BYL719 (PI3K inhibitor BYL719)

HER2-positive Breast Cancer; Recurrent Breast Cancer · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 4%임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 3

PTC+Pertuzumab (PTC+Pertuzumab)

Breast Cancer; HER2 Positive · HER2

#HER2#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleSamsung Medical CenterPhase 2

atezolizumab (Tecentriq, Pabociclib, Endocrine, Pabociclib, Endocrine(or ET + CDK4/6 inhibitors), Talazoparib, Atezolizumab, or ET + CDK4/6 inhibitors)

Premenopausal HR+/HER2- Metastatic Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleFudan UniversityPhase 2

trastuzumab (Herceptin, Paclitaxel polymer micelles combined with trastuzumab, pertuzumab, and adrelumab)

Advanced HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleShanghai JMT-Bio Inc.Phase 2

Pembolizumab (Pembolizumab)

HER2-positive Gastric Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

trastuzumab (Herceptin, Perjeta plus trastuzumab, carboplatin and docetaxel)

HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePreclinical

neoadjuvant (Pertuzumab, Pertuzumab (neoadjuvant))

HER2-positive Breast Cancer; Neoplasms · HER2

#HER2#Antibody#Preclinical#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab/Trastuzumab/Hyaluronidase-zzxf)

Breast Cancer; Breast Neoplasm · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleHenan Cancer HospitalPreclinical

trastuzumab (Herceptin, Pyrotinib and Trastuzumab plus Vinorelbine)

HER2 Positive Breast Cancer · HER2

#HER2#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
ADCBiologicstaleZhengda Tianqing Pharmaceutical…Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48+AK105+cisplatin)

Advanced Gastric Carcinoma; HER2-positive Gastric Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
AntibodystaleJiangsu HengRui Medicine Co., L…Phase 3

Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan (Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan)

HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma · HER2

#HER2#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleXijing HospitalPhase 2

RC48-ADC (Recombinant humanized anti-HER2 monoclonal antibody-MMAE coupling agent, Recombinant humanized anti-HER2 monoclonal antibody-MMAE coupling agent (RC48-ADC))

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Rilvegostomig + TDXd (Rilvegostomig + TDXd)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

proposed trastuzumab biosimilar (SB3, SB3 (proposed trastuzumab biosimilar))

Breast Neoplasms · HER2

#HER2#Antibody#Preclinical#항체#면역항체+3
효능 ORR 91.2%임상시험 1상태 DISCONTINUED
ADCBiologicstaleFudan UniversityPhase 2

SHR-4602 (SHR-4602)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING

10 / 13 페이지

← 이전다음 →